Yes. Labm’s circRNA RT-PCR MDD test offers several advantages over the Edit-B RNA-Seq test from Alcediag. It provides faster results, higher clinical specificity for Major Depressive Disorder, and is significantly more affordable (€200 per patient vs €800), making it accessible for routine clinical use. Unlike RNA sequencing, it does not require complex bioinformatics analysis and can be implemented directly in diagnostic laboratories for reliable, actionable insights.